First Feature Film of the Global Hit Anime Franchise to Screen as Five-Day Limited Engagement
SAN DIEGO, CA – JULY 20, 2018. Moments ago, during an exclusive interview with IGN, voice actors Christopher R. Sabat and Justin Briner, stars of the “My Hero Academia” series, revealed the theatrical release dates for the eagerly anticipated new film “My Hero Academia: Two Heroes.” Funimation Films can confirm that the official theatrical dates for “My Hero Academia: Two Heroes” are September 25, 26, 27, 29 and October 2, 2018.
This first ever feature film in the “My Hero Academia” franchise from Toho Co. Ltd., will screen in both Japanese (English subtitles) and English dub on separate dates during its five-day run in over 400 theaters across the U.S. and Canada. “My Hero Academia: Two Heroes” will be available in English dub on September 25, 27 and 29 and in the original Japanese (English subtitles) on September 26 and October 2. As part of today’s revelation, Funimation launched the official movie website at funimationfilms.com/myheroacademia.
“Based on the incredible response from the three thousand fans at our sold-out world premiere during Anime Expo, I have no doubt that audiences everywhere will enjoy ‘My Hero Academia: Two Heroes’ as well,” said Gen Fukunaga, CEO and President of Funimation. “The stories and characters of ’My Hero Academia’ have connected in such an incredible way with its viewers that it now has created a fan base that normally would take a decade to establish. This first feature film for the franchise does not disappoint.”
In support of the new film, Funimation is co-hosting a “My Hero Academia” panel at San Diego Comic-Con on Saturday, July 21, 2018 at 11:15 a.m. in Panel Room 6A. The panel will feature Kohei Horikoshi, creator of the My Hero Academia manga, alongside English voice actors Justin Briner and Christopher R. Sabat who portray Deku and All Might respectively in the anime series.
Our favorite young hero-in training is in for a wild ride when villains threaten the artificial moving city, I-Island. Deku and All Might receive an invitation to I-Expo, the world’s leading exhibition of Quirk abilities and hero item innovations!Amid the excitement, sponsors, and pros from all over, Deku meets Melissa, a girl who is Quirkless just like he once was. Suddenly, I-Expo’s top-of-the-line security system gets hacked by villains, and a sinister plan is set in motion. It’s a serious threat to hero society,and one man holds the key to it all—the symbol of peace, All Might.
Now in the middle of its third season, “My Hero Academia” was the most awarded anime series of 2017. Awards and accolades included IGN’s “Best of 2017 – Anime of the Year” and “2017 People’s Choice – Anime of the Year” awards, seven top honors at the Crunchyroll Anime Awards, ComicBook.com’s “2017 Golden Issue Award for Best Shonen Series” and the #1 spot on both Anime News Network’s “Best of 2017 Mega Poll” and GameSpot’s “Top Ten Anime of 2017.” For more information on My Hero Academia, visit funimation.com/myheroacademia.
Like us on Facebook at facebook.com/funimation and follow us on Twitter at twitter.com/funimation and on Instagram at instagram.com/funimation.
About Funimation Films
Funimation Films, the theatrical division of Funimation, acquires and distributes both anime and live action movies from prominent international filmmakers that appeal to the interests and passion of all types of fans throughout North America. The division was launched in December 2014 following the box office success of “Dragon Ball Z: Battle of Gods.” Its debut release, “Dragon Ball Z: Resurrection ‘F’,” was an instant blockbuster and became the #9 highest-grossing anime movie of all time in North America. Funimation Films has gone on to release numerous films including “Shin Godzilla” and the award-winning, critically acclaimed “Your Name.” Funimation, a subsidiary of Sony Pictures Television, is a fully integrated, next-generation entertainment studio based in the Dallas/Fort Worth. For more information on Funimation Films, visit funimationfilms.com.